Moreover, TGF-β–induced endogenous Smad2/3 activity was prolonged in TNF-α–treated glioblastoma cells (Figure 8G), which suggests that TNF-α sustained TGF-β–induced TGF-β/Smad activation in glioblastoma cells. The gene discussed is SMAD2; the disease is glioblastoma.